October 9, 2020

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. CDC: U.S. COVID-19 Deaths...

FRIDAY, Oct. 9, 2020 (HealthDay News) — Patients with type 2 diabetes (T2D) are more likely to develop vascular dementia and nonvascular dementia compared with controls without diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Carlos Celis-Morales,...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. CDC: U.S. COVID-19 Deaths...

FRIDAY, Oct. 9, 2020 (HealthDay News) — Manufacturer prices of insulin are considerably higher in the United States than in other countries, according to a report published by the RAND Corporation. Andrew W. Mulcahy, Ph.D., from RAND Health Care Communications in Santa Monica, California, and colleagues compared prices of insulins in the United States relative...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. CDC: U.S. COVID-19 Deaths...

Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice. CDC: U.S. COVID-19 Deaths...

FRIDAY, Oct. 9, 2020 (HealthDay News) — For patients hospitalized with COVID-19, remdesivir is superior for shortening time to recovery compared with placebo, according to a study published online Oct. 8 in the New England Journal of Medicine. John H. Beigel, M.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues conducted a...

FRIDAY, Oct. 9, 2020 (HealthDay News) — COVID-19 deaths in the United States could reach 233,000 by the end of October, the U.S. Centers for Disease Control and Prevention said Thursday. The prediction is based on data from dozens of independent models. “This week’s national ensemble forecast indicates an uncertain trend in new COVID-19 deaths...

  Examining the therapeutic efficacy of targeting FAO   By examining different novel therapies there can be a better understanding of the frontline strategy for clinical management. A research team lead by Zeyad Nassar examined the main bioenergetic pathway in prostate cancer which is fatty acid oxidation (FAO). The main targeted therapies are antigen deprivation....